Table 4

Multivariate analysis of factors that influence recurrence-free survival in 464 FIGO stage IB endocervical adenocarcinomas

VariableRecurrence-free survival
HR95% CIP value
FIGO stage1.250.72 to 2.150.42
Precursor lesions2.150.96 to 4.760.06
HPV status2.311.02 to 5.460.05
Silva pattern1.040.50 to 2.140.91
Tumor grade1.160.62 to 2.170.62
Lymphovascular invasion3.501.33 to 9.190.011
Lymph node metastases2.661.20 to 5.900.016
  • FIGO, International Federation of Gynecology and Obstetrics; HPV, human papillomavirus